Navigation Links
Existing Radiation Countermeasures Inadequate! Development of Rx100 Promises Change!

1; making it arguably the most potent such compound under development. Rx100 protects against damage to both the bone marrow as well as the critical cells of the small intestine.

Testing of Rx100 has demonstrated its unique properties in comparison to other drug candidates in the pipeline. Of significance is the fact that Rx100: a) is a small molecule, b) is essentially nontoxic at therapeutic doses, c) has a long shelf life, d) is nonimmunogenic, e) and provides effective treatment of ARS when administered up to 72 hours after exposure to lethal, whole-body radiation.

Dr. W. Shannon McCool, RxBio's CEO, points out that: "Rx100 is unique among radioprotectants / radiomitigators in that it boosts natural mechanisms that promote and sustain cell survival in almost every cell type and at the same time inhibits the cascade leading to programmed cell death (apoptosis). Thus, Rx100 augments the good and shuts down the bad. While other products shut down essential cellular signaling mechanisms involved in radiation-induced cellular injury and tend to lack specificity and/or may be toxic, Rx100 is a specific activator of natural, nontoxic, protective mechanisms of cell survival and antiapoptosis. Among its actions, Rx100 protects critical stem cells. Rx100 can be formulated for a wide range of patient types – from infants to the elderly – and can be administered either orally or subcutaneously."

In addition, Dr. Gabor Tigyi, RxBio's CSO, comments that: "Rx100 is a potent protector of the GI tract. This drug provides significant protection to the gut from radiation as well as other toxic substances such as cholera toxin. Among its actions, Rx100 maintains the mucosal barrier of the GI tract. It prevents severe diarrhea and the entry of bacterial toxins into the blood stream – both potentially severe side effects." RxBio has recently presented it's initial NHP data at the BARDA meeting that took place in January, 2011, in Washington. Th

SOURCE RxBio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Elusys Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax
2. Yongye International Expands Its Existing Production Capacity by 50% and Provides Updates on Customer List Acquisition
3. Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
4. ChemImage Works to Improve Existing Methods of Imaging Untreated Fingerprints on Paper Substrates
5. Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
6. Australian Patent Issued to CreAgri® for Ultraviolet Radiation (UVR) Protection by its Hydroxytyrosol-Based Formulations
7. Bolder BioTechnology Receives $1.2 Million from NIH to Study Long-Acting G-CSF and GM-CSF Analogs in Treating Acute Radiation Syndrome
8. Rx100 Rescues Life if Administered Up to 72 Hours After Exposure to Lethal, Whole-Body Radiation!
9. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
10. Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy Market
11. New near-field radiation therapy promises relief for overheating laptops
Post Your Comments:
(Date:10/8/2015)... 2015 Celemics, a global pioneer of personalized ... American market with the establishment of Celemics America, Inc. ... Europe , has secured itself in the ... and sample preparation for DNA sequencing and genetic testing.  ... somatic genetic testing more accurately, quickly, and cost effectively ...
(Date:10/8/2015)... 2015  Today, DuPont and Caribou Biosciences, a ... jointly announced a strategic alliance. As part of ... patent portfolios, with DuPont receiving exclusive intellectual property ... crops, and non-exclusive rights in other agricultural and ... --> In addition, the alliance ...
(Date:10/8/2015)... , Oct. 8, 2015  Sigma-Aldrich Corporation ... Cerilliant ® brand within its Applied Diagnostics ... bile acid reference standards product line with ten ... routinely tested bile acids and their stable-labeled internal ... consist of lithocholic acid, taurocholic acid and native ...
(Date:10/7/2015)... 8, 2015 ... accounts for largest bioinformatics market share due ... discovery and development process says this research ... . --> ... of applications, the bioinformatics market is segmented ...
Breaking Biology Technology:
... materials to study their structure and behavior, thanks to work ... and the Lawrence Berkeley National Laboratory and published Aug. 14 ... will enable more detailed study of new types of materials ... The technique, called angle-resolved photoemission, has been used since ...
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today ... Food and Drug Administration (FDA) that the agency has ... of the EYLEA Biologics License Application (BLA) for the ... November 18, 2011, which is a three month extension ...
... Elsevier, a world-leading provider of scientific, technical and ... University of Singapore (NUS), a leading global university ... This "Hackathon", a 24-hour programming competition, encourages students ... the search and discovery process of scientific information. ...
Cached Biology Technology:
(Date:10/8/2015)... 8. Oktober 2015 Die Track ... Unternehmen des Bereiches Tracking, hat heute bekannt ... Gefängnisbehörde Virginias (Department of Corrections – DOC) ... für alle Strafen geliefert werden, die der ... Präsident für den Amerikanischen Kontinent der Track ...
(Date:10/7/2015)... -- --> --> According ... third quarter 2015 amounted to around 960 MSEK. This exceeds ... was communicated 20 August 2015. --> ... a continued growing demand for the company,s products, the revenues ... than during the third quarter. The revenue guidance for 2015 ...
(Date:10/6/2015)... 2015 Track Group, Inc. (OTCQX: TRCK), a ... signed a contract with the Virginia Department of Corrections ... of sentences under the Department,s oversight. Derek ... contract with the Virginia DOC will expand our footprint ... our position as a trusted leader in offender electronic ...
Breaking Biology News(10 mins):
... (Dec. 20, 2007) -- At its core, healthy neurological function ... via the synapse. Figuring out how the synapse traffics ... to understanding the function of the healthy and diseased brain. ... Cornell Medical College in New York City has spotted a ...
... East Anglia has discovered the existence of grandparent helpers in ... rarely occurs except in humans, has been observed in birds. ... a population on Cousin Island in the Seychelles has revealed ... themselves often help their children to raise grandchildren. The ...
... Ph.D, a University of Alabama at Birmingham (UAB) professor ... Czech Mind prize. The annual award is ... recipients often include Czech nationals working in other countries. ... to research and teach about the microbial environment of ...
Cached Biology News: